Imperial Hotel,Ltd. FY2026 Q3 Earnings Report

Quick View

Executive Summary

FY2026 Q3 results were Revenue ¥419.7B (YoY +¥26.1B +6.6%), Operating Income ¥25.6B (YoY +¥9.8B +62.7%), Ordinary Income ¥29.1B (YoY +¥10.4B +55.7%), and Net Income ¥28.7B (YoY +¥4.7B +19.3%). Operating Income rose significantly from ¥15.8B to ¥25.6B, and the Operating Margin improved by 2.3pt from 3.8% to 6.1%. Non-operating income of ¥3.5B contributed to Ordinary Income, and an extraordinary gain on sales of marketable securities of ¥5.6B contributed to Net Income. Total assets increased to ¥801.9B (YoY +¥111.6B), and net assets rose to ¥472.6B (YoY +¥19.1B). Profitability improved on higher revenue and better cost management, but note that non-recurring factors such as gains on sales of marketable securities account for part of Net Income.

Key Financial Metrics

[Profitability] ROE 6.1% (improved from 5.8% a year earlier), Operating Margin 6.1% (+2.1pt from 4.0% a year earlier), Net Profit Margin 6.8% (+0.7pt from 6.1% a year earlier). Return on Assets is equivalent to an annualized 4.8%. The sharp increase in Operating Income (+62.7%) drove profitability improvement, but the extraordinary gain on sales of marketable securities of ¥5.6B lifted Net Income by the equivalent of 19.6%, necessitating confirmation of the sustainability of operating fundamentals excluding non-recurring factors. [Cash Quality] Cash and deposits of ¥141.5B provide 1.57x coverage of short-term borrowings of ¥90.0B. Current assets are ¥348.8B, and the current ratio is 205.8%, indicating sound short-term liquidity. Accounts receivable of ¥38.6B (YoY +28.4%) and accounts payable of ¥17.7B (YoY +57.9%) increased, indicating an expanding working capital trend. [Investment Efficiency] Total Asset Turnover is 0.523x, roughly unchanged YoY. Financial leverage is 1.70x, a conservative level. [Financial Soundness] Equity Ratio 58.9% (down from 65.7% a year earlier); interest-bearing debt of ¥90.0B consists entirely of short-term borrowings. Debt-to-Equity ratio is 0.70x, and the Net Debt/EBITDA multiple is in negative territory due to ample cash. The 100% short-term debt composition is the largest concern as it concentrates refinancing risk.

Cash Flow Analysis

As the statement of cash flows data is not disclosed, funding trends are analyzed from changes in the balance sheet. Cash and deposits increased by ¥24.0B from ¥117.5B to ¥141.5B, which is presumed to reflect contribution from higher operating profits. On the working capital front, accounts receivable increased by ¥8.5B and accounts payable by ¥6.5B, confirming higher working capital needs accompanying revenue growth. In investing activities, construction in progress decreased from ¥25.3B to ¥9.1B, suggesting completion or disposal of certain projects. An extraordinary gain on sales of marketable securities of ¥5.6B was recorded, indicating cash recovery through asset sales. In financing activities, short-term borrowings stand at ¥90.0B, unchanged YoY, implying no large changes in borrowings. Treasury stock increased from ¥0.9B to ¥4.1B, suggesting the possibility of share repurchases. Cash coverage of short-term borrowings is 1.57x, securing near-term repayment capacity, but the concentration of all interest-bearing debt in the short term necessitates confirmation of the refinancing plan.

Quality of Earnings

With Ordinary Income of ¥29.1B and Operating Income of ¥25.6B, net non-operating income totaled approximately ¥3.5B. Although the breakdown of non-operating income is not disclosed, it is presumed to consist mainly of financial income such as dividends received and interest income. An extraordinary gain on sales of marketable securities of ¥5.6B was recorded as special income, equivalent to 19.6% of Net Income of ¥28.7B. Excluding the non-recurring gain on sales of marketable securities, operating-based Net Income would be around ¥23B, and the Net Profit Margin would decline to approximately 5.5%. Corporate taxes of ¥0.7B against profit before tax of ¥29.4B imply a very low effective tax rate of about 2.4%, suggesting the impact of tax effects or utilization/reversal of deferred tax assets. The Operating Margin is 6.1%, improved from 4.0% a year earlier, but below the industry median of 8.2%, indicating room for further cost management improvements. As Operating Cash Flow disclosure is absent, cash backing of earnings cannot be confirmed, but the increase in cash and deposits and the trend in accounts receivable suggest a certain level of cash generation. Overall, the improvement in Operating Income is commendable, but sustainable earning power excluding dependence on special gains and low tax rates should be confirmed via Operating Cash Flow.

Risk Factors

1. Concentration Risk in Short-term Borrowings: All interest-bearing debt of ¥90.0B consists of short-term borrowings, resulting in a 100% short-term debt ratio. There is elevated refinancing risk in the event of worsening rollover conditions or changes in the financial environment. Although cash and deposits of ¥141.5B secure short-term repayment capacity, converting to long-term borrowings and clarifying the repayment plan remain issues.
2. Liquidity Pressure from Working Capital Expansion: Working capital is expanding with accounts receivable +28.4% and accounts payable +57.9%, confirming increased funding needs alongside revenue growth. Lengthening of the collection cycle and inventory burdens (inventory is undisclosed but is an important metric in peer companies) could pressure liquidity.
3. Reliance on Non-recurring Gains and Earnings Sustainability: The ¥5.6B extraordinary gain on sales of marketable securities accounts for about 20% of Net Income, and operating-based profit generation is limited. With an effective tax rate of 2.4%, Net Income could decline if tax benefits fade. As Operating Cash Flow backing is unknown, verification of the cash realization quality of earnings is necessary.

Industry Benchmark (Reference; In-house Research)

[Industry Positioning] (Reference information; in-house research) Compared with data for 44 Healthcare companies in 2025 Q3, the positioning is as follows. Profitability: The 6.1% Operating Margin is 2.1pt below the industry median of 8.2%, slightly above the IQR lower bound of 5.2%, placing the company in the mid-to-lower range within the industry. The 6.8% Net Profit Margin is 1.1pt above the industry median of 5.7%, positioned slightly above the center of the IQR range (3.1%–9.1%), but excluding special gains it would be approximately 5.5%, roughly in line with the median. ROE 6.1% is 3.6pt below the industry median of 9.7%, above the IQR lower bound of 3.9% but still low within the industry. Soundness: The Equity Ratio of 58.9% is 9.9pt above the industry median of 49.0%, placing it in the upper range of the IQR (38.8%–66.3%) and indicating relatively high financial safety. The current ratio of 205.8% (2.06x) is roughly in line with the industry median of 2.06x, ensuring standard liquidity. The Net Debt/EBITDA multiple is in negative territory and below the industry median of -1.75 (reflecting larger excess cash), indicating solid financial flexibility. Efficiency: ROA equivalent of 4.8% is roughly in line with the industry median of 4.7%, indicating a standard level. Growth: Revenue growth of +6.6% is 2.9pt below the industry median of 9.5%, above the IQR lower bound of 2.7% but placing growth in the mid-to-lower range within the industry. Overall, while financial soundness is at a favorable level within the industry, profitability and growth are mid-to-lower tier, with particularly ample scope to improve the Operating Margin. Industry: Healthcare (44 companies); Comparison period: 2025 Q3; Source: In-house aggregation

Key Takeaways from Results

1. Improvement and Sustainability of Operating Margin: The Operating Margin improved by 2.1pt from 4.0% to 6.1%, and Operating Income increased significantly by +62.7%. The magnitude of operating profit growth relative to +6.6% revenue growth suggests cost structure improvements and fixed cost absorption. However, the 6.1% Operating Margin is below the industry median of 8.2%, and selling, general and administrative expenses of ¥313.9B (74.8% of revenue) remain high and weigh on profitability. If disclosure of Operating Cash Flow confirms the cash realization quality of Operating Income, it will enable assessment of a sustainable profit improvement trend.
2. Concentration of Short-term Borrowings and Need to Review Capital Policy: Interest-bearing debt of ¥90.0B comprises only short-term borrowings, implying refinancing concentration risk. While cash and deposits of ¥141.5B place the company in a net cash position and secure near-term liquidity, the absence of clarity on conversion to long-term borrowings or a repayment plan warrants attention. The full-year outlook includes a planned dividend of ¥4.0, and while the Payout Ratio of approximately 25% is conservative, confirming FCF generation and optimizing the borrowing mix are keys to improving capital efficiency.
3. Need to Assess Underlying Performance Excluding Non-recurring Factors: Non-recurring factors—a ¥5.6B extraordinary gain on sales of marketable securities and a 2.4% effective tax rate—are boosting Net Income. Excluding these, operating-based profit is estimated at around ¥23B (equivalent to a 5.5% Net Profit Margin), and alignment with the full-year Operating Income forecast of ¥16.0B needs to be verified. Given that cumulative Operating Income is ¥25.6B through Q3 versus the full-year forecast of ¥16.0B, this appears to reflect a downward revision already made or seasonality; profit trends from Q4 onward and developments in working capital management are key watch points.

---

This report is an earnings analysis document automatically generated by AI analyzing XBRL earnings release data. It is not a solicitation to invest in any particular security. The industry benchmark is reference information aggregated by our company based on publicly available financial statements. Investment decisions are your own responsibility; please consult a professional as necessary.